Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine

American Sociological Review

Volumn 68, Issue 2, 2003, Pages 161-194

  Clarke, Adele E ^a   Shim, Janet K ^a   Mamo, Laura ^b   Fosket, Jennifer Ruth ^a   Fishman, Jennifer R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85080472504     PISSN: 00031224     EISSN: 19398271     Source Type: Journal    
DOI: 10.1177/000312240306800201     Document Type: Article

References (253)

1. Abate Tom. 2000a. “Gene Research Project Sets New Standard for Supercomputer Power.” San Francisco Chronicle, December 18, p. D1.
2. Abate Tom. 2000b. “World Health Leaders Discuss Ways to Bridge the Medical Divide.” San Francisco Chronicle, February 21, pp. B1, B5.
3. Abbott Andrew. 1988. The System of Professions: An Essay on the Division of Expert Labor. Chicago, IL: University of Chicago Press.
4. Abir-Am Pnina. 1985. “Themes, Genres, and Orders of Legitimation in the Consolidation of New Disciplines: Deconstructing the Historiography of Molecular Biology.” History of Science 23:73–117.
5. Adams Vincanne. 2002. “Randomized Controlled Crime: Indirect Criminalization of Alternative Medicine in the United States.” Social Studies of Science 32:659–90.
6. Anderson Warwick. 2002. “Postcolonial Technoscience Studies: An Introduction.” Social Studies of Science 32:643–58.
7. Armstrong David. 1995. “The Rise of Surveillance Medicine.” Sociology of Health and Illness 17:393–404.
8. Armstrong David. 2000. “Social Theorizing about Health and Illness.” Pp. 24–35 in Handbook of Social Studies in Health and Medicine, edited by Albrecht G. L., Fitzpatrick R., and Scrimshaw S.C.. Thousand Oaks, CA: Sage.
9. Arney William Ray and Bergen Bernard J.. 1984. Medicine and the Management of Living. Chicago, IL: University of Chicago Press.
10. Arnold David, ed. 1988. Imperial Medicine and Indigenous Societies. Manchester, England: Manchester University Press.
11. Bagnall Janet. 2001. “Test Genes Should Be Public.” Montreal Gazette, November 8, p. B3.
12. Bastian Hilda. 2002. “Promoting Drugs through Hairdressers? Is Nothing Sacred?” British Medical Journal 325:1180.
13. Bauer Martin. 1998. “The Medicalization of Science News—From the ‘Rocket-Scalpel’ to the ‘Gene-Meteorite’ Complex.” Information sur les Sciences Sociales 37:731–51.
14. Becker Gay. 2000. “Selling Hope: Marketing and Consuming the New Reproductive Technologies in the United States” (in French). Sciences Sociales et Sante 18:105–25.
15. Becker Howard S., Geer Blanche, Hughes Everett C., and Strauss Anselm L.. 1961. Boys in White: Student Culture in Medical School. Chicago, IL: University of Chicago Press.
16. Bekelman J.E., Li Y., and Gross C.P.. 2003. “Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review.” Journal of the American Medical Association 289:454–65.
17. Belkin Lisa 1996. “Charity Begins at … The Marketing Meeting, The Gala Event, The Product Tie-In.” New York Times Magazine, December 22, pp. 40–58.
18. Berg Marc. 1997. Rationalizing Medical Work: Decision-Support Techniques and Medical Practices. Cambridge, MA: MIT Press.
19. Berg Marc. 2000. “Orders and Their Others: On the Constitution of Universalities in Medical Work.” Configurations 8:31–61.
20. Bishop J.W., Marshall C.J., and Bentz J.S.. 2000. “New Technologies in Gynecologic Cytology.” Journal of Reproductive Medicine 45:701–19.
21. Blois Marsden S. 1984. Information and Medicine: The Nature of Medical Descriptions. Berkeley, CA: University of California Press.
22. Bolter J. David and Grusin Richard. 1999. Remediation: Understanding New Media. Cambridge, MA: MIT Press.
23. Bond Patricia and Weissman Robert. 1997. “The Costs of Mergers and Acquisitions.” International Journal of Health Services 27:88–97.
24. Boston Women's Health Book Collective. 1971. Our Bodies, Ourselves. Boston, MA: South End.
25. Bowker Geoffrey C. and Star Susan Leigh. 1999. Sorting Things Out: Classification and Its Consequences. Cambridge, MA: MIT Press.
26. Brown Phil. 1995. “Popular Epidemiology, Toxic Waste, and Social Movements.” Pp. 91–112 in Medicine, Health, and Risk: Sociological Approaches, edited by Gabe J.. Oxford, England: Blackwell.
27. Brown Phil, Zavestoski Steve, McCormick Sabrina, Mandelbaum Joshua, Luebke Theo, and Linder Meadow. 2001. “A Gulf of Difference: Disputes over Gulf War-Related Illnesses.” Journal of Health and Social Behavior 42:235–57.
28. Buchanan Allen, Brock Dan W., Daniels Norman, and Winkler Daniel. 2000. From Chance to Choice: Genetics and Justice. Cambridge, England: Cambridge University Press.
29. Bucher Rue. 1962. “Pathology: A Study of Social Movements within a Profession.” Social Problems 10:40–51.
30. Bucher Rue and Strauss Anselm L.. 1961. “Professions in Process.” American Journal of Sociology 66:325–34.
31. Bud Robert, Finn Bernard, and Trischler Helmuth, eds. 1999. Manifesting Medicine: Bodies and Machines. Amsterdam, The Netherlands: Harwood Academic.
32. Bunton Robin, Nettleton Sarah, and Burrows Roger, eds. 1995. The Sociology of Health Promotion: Health, Risk, and Consumption Under Late Modernity. London, England: Routledge.
33. Bury Michael R. 1986. “Social Constructionism and the Development of Medical Sociology.” Sociology of Health and Illness 8:137–69.
34. Callahan Daniel. 1998. False Hopes: Overcoming the Obstacles to a Sustainable, Affordable Medicine. New Brunswick, NJ: Rutgers University Press.
35. Cartwright Lisa. 2000. “Reach Out and Heal Someone: Telemedicine and the Globalization of Health Care.” Health 4:347–77.
36. Casper Monica and Koenig Barbara. 1996. “Reconfiguring Nature and Culture: Intersections of Medical Anthropology and Technoscience Studies.” Medical Anthropology Quarterly 10:523–36.
37. Castel Robert. 1991. “From Dangerousness to Risk.” Pp. 281–98 in The Foucault Effect, edited by Burchell G., Gordon C., and Miller P.. Chicago, IL: University of Chicago Press.
38. Chadarevian Soraya de and Kamminga Harmke. 1998. Molecularizing Biology and Medicine: New Practices and Alliances, 1910s–1970s. Amsterdam, The Netherlands: Harwood Academic.
39. Charatan F. 2000. “U.S. Prescription Drug Sales Boosted by Advertising.” British Medical Journal 321:783.
40. Charmaz Kathy. 1991. Good Days, Bad Days: The Self in Chronic Illness and Time. New Brunswick, NJ: Rutgers University Press.
41. Clarke Adele E. 1987. “Research Materials and Reproductive Science in the United States, 1910–1940.” Pp. 323–50 in Physiology in the American Context, 1850–1940, edited by Geison G. L.. Bethesda, MD: American Physiological Society.
42. Clarke Adele E. 1988. “Toward Understanding Medical Experimentalism: The Life Sciences in the American Context.” Paper presented at the conference on the History of Twentieth Century Health Sciences, November, San Francisco, CA.
43. Clarke Adele E. 1991. “Social Worlds/Arenas Theory as Organizational Theory.” Pp. 128–35 in Social Organization and Social Process: Essays in Honor of Anselm Strauss, edited by Maines D. R.. Hawthorne, NY: Aldine de Gruyter.
44. Clarke Adele E. 1995. “Modernity, Postmodernity, and Reproductive Processes ca. 1890–1990 or, ‘Mommy, Where Do Cyborgs Come From Anyway?”’ Pp. 139–55 in The Cyborg Handbook, edited by Gray C.H., Figueroa-Sarriera H.J., and Mentor S.. New York: Routledge.
45. Clarke Adele E. and Montini Theresa. 1993. “The Many Faces of RU486: Tales of Situated Knowledges and Technological Contestations.” Science, Technology, and Human Values 18:42–78.
46. Clarke Adele E. and Olesen Virginia L.. 1999. “Revising, Diffracting, Acting.” Pp. 3–48 in Revisioning Women, Health, and Healing: Feminist, Cultural, and Technoscience Perspectives, edited by Clarke A. E. and Olesen V. L.. New York: Routledge.
47. Clarke Adele E., Shim Janet, Fosket Jennifer, Fishman Jennifer, and Mamo Laura. 2000. “Technoscience and the New Biomedicalization: Western Roots, Global Rhizomes” (in French). Sciences Sociales et Sante 18:11–42.
48. Clarke Adele E., Shim Janet, Mamo Laura, Fosket Jennifer, and Fishman Jennifer, eds. In prep. Biomedicalization Studies: Technoscientific Transformations of Health and Illness in the U.S. Book manuscript.
49. Cohen Carl I. 1991. “Old Age, Gender, and Physical Activity: The Biomedicalization of Aging.” Journal of Sport History 18:64–80.
50. Cohen Carl I. 1993. “The Biomedicalization of Psychiatry: A Critical Overview.” Community Mental Health Journal 29:509–21.
51. Cohen Lawrence. 1999. “Where It Hurts: Indian Material for an Ethics of Organ Transplantation.” Daedalus 128:135–65.
52. Conrad Peter. 1975. “The Discovery of Hyper-kinesis: Notes on the Medicalization of Deviant Behavior.” Social Problems 23:12–21.
53. Conrad Peter. 1992. “Medicalization and Social Control.” Annual Review of Sociology 18:209–32.
54. Conrad Peter. 2000. “Medicalization, Genetics, and Human Problems.” Pp. 322–33 in Handbook of Medical Sociology, edited by Bird C.E., Conrad P., and Fremont A.. Thousand Oaks, CA: Sage.
55. Conrad Peter and Potter Deborah. 2000. “From Hyperactive Children to ADHD Adults: Observations on the Expansion of Medical Categories.” Social Problems 47:559–82.
56. Conrad Peter and Schneider Joseph. 1980. Deviance and Medicalization: From Badness to Sickness. St. Louis, MO: C. V. Mosby.
57. Crawford Robert. 1985. “A Cultural Account of ‘Health’: Control, Release, and the Social Body.” Pp. 60–106 in Issues in the Political Economy of Health, edited by McKinlay J. B.. New York: Methuen-Tavistock.
58. Crawford Robert. 1994. “The Boundaries of the Self and the Unhealthy Other: Reflections on Health, Culture, and AIDS.” Social Science and Medicine 38:1347–65.
59. Crawford Robert. 1999. “Transgression for What? A Response to Simon Williams.” Health 3:355–66.
60. Davidoff F., DeAngelis C. D., Drazen J. M., Hoey J., Hojgaard L., Horton R., Kotzin S., Nicholls M. G., Nylenna M., Overbeke A. J., Sox H. C., Van Der Weyden M. B., and Wilkes M. S.. 2001. “Sponsorship, Authorship, and Accountability.” Journal of the American Medical Association 286:1232–4.
61. Deleuze Gilles and Guattari Felix. 1987. A Thousand Plateaus: Capitalism and Schizophrenia. Minneapolis, MN: University of Minnesota Press.
62. Delmonico Francis L., Arnold Robert, Scheper-Hughes Nancy, Siminoff Laura A., Kahn Jeffrey, and Younger Stuart J.. 2002. “Sounding Board: Ethical Incentives—Not Payment—For Organ Donation.” New England Journal of Medicine 346:2002–5.
63. Dumit Joseph. 1997. “A Digital Image of the Category of the Person: PET Scanning and Objective Self-Fashioning.” Pp. 83–102 in Cyborgs and Citadels: Anthropological Interventions in Emerging Sciences, Technologies, and Medicines, edited by Downey G. L. and Dumit J.. Santa Fe, NM: School of American Research.
64. Edgley Charles and Brissett Dennis. 1990. “Health Nazis and the Cult of the Perfect Body: Some Polemical Observations.” Symbolic Interaction 31:257–80.
65. Ehrenreich Barbara and Ehrenreich John. 1971. The American Health Empire: Power, Profits, and Politics. A HealthPAC Book. New York: Vintage.
66. Ehrenreich Barbara and Ehrenreich John. 1978. “Medicine as Social Control.” Pp. 39–79 in The Cultural Crisis of Modern Medicine, edited by Ehrenreich J.. New York: Monthly Review.
67. Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van Rompay M., and Kessler R. C.. 1998. “Trends in Alternative Medicine Use in the U.S., 1990–1997: Results of a Follow-up National Survey.” Journal of the American Medical Association 280:1569–75.
68. Eisenberg D. M., Kessler R. C., Foster C., Norlock F. E., Calkins D. R., and Delbanco T. L.. 1993. “Unconventional Medicine in the U.S.: Prevalence, Costs, and Patterns of Use.” New England Journal of Medicine 328:346–52.
69. Ellrodt G., Cook D. J., Lee J., Cho M., Hunt D., and Weingarten S.. 1997. “Evidence-Based Disease Management.” Journal of the American Medical Association 278:1687–92.
70. Epstein Steven. 1996. Impure Science: AIDS, Activism, and the Politics of Knowledge. Berkeley, CA: University of California Press.
71. Epstein Steven. Forthcoming. “Bodily Differences and Collective Identities: Representation, Generalizability, and the Politics of Gender and Race in Biomedical Research in the United States.” Body and Society.
72. Estes Carroll L. 1991. “The Reagan Legacy: Privatization, the Welfare State, and Aging.” Pp. 59–83 in States, Labor Markets, and the Future of Old Age Policy, edited by Myles J. and Quadagno J.. Philadelphia, PA: Temple University Press.
73. Estes Carroll L. and Binney Elizabeth A.. 1989. “The Biomedicalization of Aging: Dangers and Dilemmas.” Gerontologist 29:587–96.
74. Estes Carroll L., Harrington Charlene, and Pellow David N.. 2000. “The Medical Industrial Complex.” Pp. 1818–32 in The Encyclopedia of Sociology, edited by Borgatta E. F. and Montgomery R. V.. Farmington Hills, MI: Gale Group.
75. Estes Carroll L. and Linkins Karen W.. 1997. “Devolution and Aging Policy: Racing to the Bottom of Long Term Care?” International Journal of Health Services 27:427–42.
76. Ewald François. 1990. “Norms, Discipline, and the Law.” Representations 30:138–61.
77. Featherstone Mike. 1991. “The Body in Consumer Culture.” Pp. 170–96 in The Body: Social Process and Cultural Theory, edited by Featherstone M., Hepworth M., and Turner B. S.. London, England: Sage.
78. Figert Anne E. 1996. Women and the Ownership of PMS: The Structuring of a Psychiatric Disorder. New York: Aldine de Gruyter.
79. Fishman Jennifer R. Forthcoming. “Sex, Science, and Pharmaceutical Innovation: A Genealogy of Male and Female Sexual Dysfunction.” Ph.D. dissertation, Department of Social and Behavioral Sciences, University of California, San Francisco, CA.
80. Fishman Jennifer R. 2000. “Breast Cancer: Risk, Science, and Environmental Activism in an ‘At Risk’ Community.” Pp. 181–204 in Ideologies of Breast Cancer: Feminist Perspectives, edited by Potts L.. New York: St. Martin's.
81. Fishman Jennifer R. and Mamo Laura. 2002. “What's in a Disorder? A Cultural Analysis of the Medical and Pharmaceutical Constructions of Male and Female Sexual Dysfunction.” Women and Therapy 24:179–93.
82. Fishman Linda E. and Bentley James D.. 1997. “The Evolution of Support for Safety-Net Hospitals.” Health Affairs 16:30–47.
83. Fleck Ludwik. [1935] 1979. Genesis and Development of a Scientific Fact. Chicago, IL: University of Chicago Press.
84. Forsythe Diana E. 1996. “New Bottles, Old Wine: Hidden Cultural Assumptions in a Computerized Explanation System for Migraine Sufferers.” Medical Anthropology Quarterly 10:551–74.
85. Fosket Jennifer Ruth. 2002. “Breast Cancer Risk and the Politics of Prevention: Analysis of a Clinical Trial.” Ph.D. dissertation, Department of Social and Behavioral Sciences, University of California, San Francisco, CA.
86. Foucault Michel. 1975. The Birth of the Clinic: An Archaeology of Medical Perception. New York: Vintage.
87. Foucault Michel. 1980. Power/Knowledge: Selected Interviews and Other Writings, 1972–1977. New York: Pantheon.
88. Foucault Michel. 1988. “Technologies of the Self.” Pp. 16–49 in Technologies of the Self: A Seminar with Michel Foucault, edited by Martin L. H., Gutman H., and Hutton P. H.. Amherst, MA: University of Massachusetts Press.
89. Foucault Michel. 1991. “Governmentality.” Pp. 87–194 in The Foucault Effect, edited by Burchell G., Gordon C., and Miller P.. Brighton, England: Harvester Wheatsheaf.
90. Fox Renee C. 1977. “The Medicalization and Demedicalization of American Society.” Daedalus 106:9–22.
91. Fox Renee C. 2001. “Medical Uncertainty Revisited.” Pp. 236–53 in Gender, Health, and Healing: The Public/Private Divide, edited by Bendelow G., Carpenter M., Vautier C., and Williams S.. London, England: Routledge.
92. Freidson Eliot. 1970. Profession of Medicine: A Study in the Sociology of Applied Knowledge. Chicago, IL: University of Chicago Press.
93. Freidson Eliot. 2001. Professionalism: The Third Logic. Chicago, IL: University of Chicago Press.
94. Freudenheim Milt and Petersen Melody. 2001. “The Drug-Price Express Runs into a Wall.” New York Times, December 23, pp. BU1, 13.
95. Fujimura Joan H. 1999. “The Practices and Politics of Producing Meaning in the Human Genome Project.” Sociology of Science Yearbook 21:49–87.
96. Gaudilliere Jean-Paul and Lowy Ilana, eds. 1998. The Invisible Industrialist: Manufacturers and the Construction of Scientific Knowledge. London, England: MacMillan/St. Martin's.
97. Genteric Inc. 2001. “Genteric Announces Breakthrough Gene Therapy in a Pill: First Patent Ever Awarded for Oral Delivery of Non-Viral Gene Therapy.” Press release. Retrieved November 19, 2001 (http://www.genteric.com/frames.html?press).
98. Gevitz Norman. 1988. “A Coarse Sieve: Basic Science Boards and Medical Licensure in the United States.” Journal of the History of Medicine 43:36–63.
99. Gifford Sandra. 1986. “The Meaning of Lumps: A Case Study of the Ambiguities of Risk.” Pp. 213–46 in Anthropology and Epidemiology: Interdisciplinary Approaches to the Study of Health and Disease, edited by Janes C. R., Stall R., and Gifford S.M.. Boston, MA: Reidel.
100. Ginsburg Faye and Rapp Rayna. 1995. Conceiving the New World Order: The Global Politics of Reproduction. Berkeley, CA: University of California Press.
101. Goffman Erving. 1963. Stigma: Notes on the Management of Spoiled Identity. Englewood Cliffs, NJ: Spectrum.
102. Gray Chris Hables, Figueroa-Sarriera Heidi J., and Mentor Steven, eds. 1995. The Cyborg Handbook. New York: Routledge.
103. Hacking Ian. 1983. Representing and Intervening: Introductory Topics in the Philosophy of Natural Science. Cambridge, England: Cambridge University Press.
104. Halpern Sydney. 1990. “Medicalization as a Professional Process: Post War Trends in Pediatrics.” Journal of Health and Social Behavior 31:28–42.
105. Hannerz Ulf. 1996. Transnational Connections: Culture, People, Places. London, England: Routledge.
106. Haraway Donna. 1991. Simians, Cyborgs, and Women: The Reinvention of Nature. New York: Routledge.
107. Haraway Donna. 1997. Modest_Witness@Second_Millennium.FemaleMan@_Meets_Oncomouse™: Feminism and Technoscience. New York: Routledge.
108. Harvey David. 1989. The Condition of Post-modernity. Oxford, England: Blackwell.
109. Hayles N. Katherine. 1999. How We Became Posthuman: Virtual Bodies in Cybernetics, Literature, and Informatics. Chicago, IL: University of Chicago Press.
110. Hedgecoe Adam. 2001. “Schizophrenia and the Narrative of Enlightened Geneticization.” Social Studies of Science 31:375–411.
111. Heimer Matthew. 2002. “Club Med.” Smart Money, July, p. 82.
112. Hodgetts Darrin and Chamberlain Kerry. 1999. “Medicalization and the Depiction of Lay People in Television Health Documentary.” Health 3:317–33.
113. Hogle Linda. 1999. Recovering the Nation's Body: Cultural Memory, Medicine, and the Politics of Redemption. New Brunswick, NJ: Rutgers University Press.
114. Hogle Linda. 2000. “Regulating Human Tissue Innovations: Hybrid Forms of Nature and Governmentality” (in French). Sciences Sociales et Sante 18:53–74.
115. Howson Alexandra. 1998a. “Embodied Obligation: The Female Body and Health Surveillance.” Pp. 218–41 in The Body in Everyday Life, edited by Nettleton S. and Watson J.. New York: Routledge.
116. Howson Alexandra. 1998b. “Surveillance, Knowledge, and Risk: The Embodied Experience of Cervical Screening.” Health 2:195–215.
117. Hunt Linda M. and Arar Nedal H.. 2001. “An Analytical Framework for Contrasting Patient and Provider Views of the Process of Chronic Disease Management.” Medical Anthropology Quarterly 15:347–67.
118. Illich Ivan. 1976. Medical Nemesis: The Expropriation of Health. New York: Pantheon.
119. Institute of Medicine. 1999. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy of the Sciences.
120. Jasanoff Sheila. 2000. “Reconstructing the Past, Constructing the Present: Can Science Studies and the History of Science Live Happily Ever After?” Social Studies of Science 30:621–31.
121. Kaiser Family Foundation. 2001. Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising. Menlo Park, CA: Henry J. Kaiser Family Foundation.
122. Karlberg Kristen. 2000. “The Work of Genetic Care Providers: Managing Uncertainty and Ambiguity.” Pp. 81–97 in Research in the Sociology of Health Care, vol. 17, edited by Kronenfeld J.J.. Stamford, CT: JAI Press.
123. Kevles Bettyann Holtzman. 1997. Naked to the Bone: Medical Imaging in the Twentieth Century. New York: Norton.
124. Koenig Barbara. 1988. “The Technological Imperative in Medical Practice: The Social Creation of a Routine Treatment.” Pp. 465–96 in Biomedicine Examined, edited by Lock M. and Gordon D.. Boston, MA: Kluwer Academic.
125. Kohler Robert E. 1991. Partners in Science: Foundations and Natural Scientists, 1900–1945. Chicago, IL: University of Chicago Press.
126. Kolko Beth E., Nakamura Lisa, and Rodman Gilbert B., eds. 2000. Race in Cyberspace. New York: Routledge.
127. Kroll-Smith Steve and Hugh Floyd H.. 1997. Bodies in Protest: Environmental Illness and the Struggle over Medical Knowledge. New York: New York University Press.
128. Landecker Hannah. 1999. “Between Beneficence and Chattel: The Human Biological in Law and Science.” Science in Context 12:203–25.
129. Latour Bruno. 1987. Science in Action: How to Follow Scientists and Engineers through Society. Cambridge, MA: Harvard University Press.
130. Leonhardt David. 2001. “Health Care as Main Engine: Is That So Bad?” New York Times, November 11, Money and Business Section, pp. 1, 12.
131. Lewis Michael. 2000. The New New Thing: A Silicon Valley Story. New York: Norton.
132. Light Donald. 2000a. “The Sociological Character of Health Care Markets.” Pp. 394–408 in Handbook of Social Studies in Health and Medicine, edited by Albrecht G.L., Fitzpatrick R., and Scrimshaw S.C.. Thousand Oaks, CA: Sage.
133. Light Donald. 2000b. “The Medical Profession and Organizational Change: From Professional Dominance to Countervailing Power.” Pp. 201–16 in Handbook of Medical Sociology, edited by Bird C. E., Conrad P., and Fremont A. M.. Upper Saddle River, NJ: Prentice Hall.
134. Lippman Abby. 1992. “Prenatal Diagnosis: Can What Counts Be Counted?” Women and Health 18(2): 1–8.
135. Litt Jacqueline S. 2000. Medicalized Motherhood: Perspectives from the Lives of African American Women and Jewish Women. New Brunswick, NJ: Rutgers University Press.
136. Lock Margaret M. 1993. Encounters with Aging: Mythologies of Menopause in Japan and North America. Berkeley, CA: University of California Press.
137. Lock Margaret M. 1998. “Situating Women in the Politics of Health.” Pp. 178–204 in The Politics of Women's Health: Exploring Agency and Autonomy, edited by Sherwin S.. Philadelphia, PA: Temple University Press.
138. Lock Margaret and Gordon Deborah, eds. 1988. Biomedicine Examined. Boston, MA: Kluwer Academic.
139. Lock Margaret and Kaufert Patricia A., eds. 1998. Pragmatic Women and Body Politics. New York: Cambridge University Press.
140. Lohr Steve. 2000. “Welcome to the Internet, the First Global Colony.” New York Times, January 9, Section 4, pp. 1ff.
141. Lupton Deborah. 1993. “Risk as Moral Danger: The Social and Political Functions of Risk Discourse in Public Health.” International Journal of Health Services 23:425–35.
142. Lupton Deborah. 1994. Medicine as Culture: Illness, Disease, and the Body in Western Society. London, England: Sage.
143. Lupton Deborah. 1995. The Imperative of Health: Public Health and the Regulated Body. Thousand Oaks, CA: Sage.
144. Lupton Deborah. 1999. Risk. London, England: Routledge.
145. Lupton Deborah. 2000. “The Social Construction of Medicine and the Body.” Pp. 50–63 in Handbook of Social Studies in Health and Medicine, edited by Albrecht G.L., Fitzpatrick R., and Scrimshaw S.C.. London, England: Sage.
146. Lyman Karen A. 1989. “Bringing the Social Back In: A Critique of the Biomedicalization of Dementia.” Gerontologist 29:597–605.
147. MacKenzie Donald. 2001. Mechanizing Proof: Computing, Risk, and Trust. Cambridge, MA: MIT Press.
148. Mamo Laura. 2002. “Sexuality, Reproduction, and Biomedical Negotiations: An Analysis of Achieving Pregnancy in the Absence of Heterosexuality.” Ph.D. dissertation, Department of Social and Behavioral Sciences, University of California, San Francisco, CA.
149. Mamo Laura and Fishman Jennifer. 2001. “Potency in All the Right Places: Viagra as a Technology of the Gendered Body.” Body and Society 7:13–35.
150. Marks Harry M. 1993. “Medical Technologies: Social Contexts and Consequences.” Pp. 1592–1618 in Companion Encyclopedia of the History of Medicine, vol. 1, edited by Bynum W. F. and Porter R.. New York: Routledge.
151. Marks Harry M. 1997. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990. New York: Cambridge University Press.
152. Martin Emily. 1994. Flexible Bodies: The Role of Immunity in American Culture from the Days of Polio to the Age of AIDS. Boston, MA: Beacon.
153. McInaney Maureen. 2000. “Group Appointments Can Benefit Busy Doctors and Chronically Ill Patients.” UCSF News Service Release, October 18.
154. McKinlay John B. and Stoeckle John D.. 1988. “Corporatization and the Social Transformation of Doctoring.” International Journal of Health Services 18:191–205.
155. Mechanic David. 2002. “Socio-Cultural Implications of Changing Organizational Technologies in the Provision of Care.” Social Science and Medicine 54:459–67.
156. Meckler Laura. 2003. “Uninsured Population Continues to Expand.” San Francisco Chronicle, March 5, p. A4.
157. Mills Robert J. 2002. “Health Insurance Coverage: 2001.” U.S. Census Bureau (September). Retrieved September 20, 2002 (http://www.census.gov/prod/2002pubs/p60–220.pdf).
158. Montini Theresa. 1996. “Gender and Emotions in the Advocacy for Breast Cancer Informed Consent Legislation.” Gender and Society 10:9–23.
159. Morgan Kathryn Pauly. 1998. “Contested Bodies, Contested Knowledges: Women, Health, and the Politics of Medicalization.” Pp. 83–121 in The Politics of Women's Health: Exploring Agency and Autonomy, edited by Sherwin S.. Philadelphia, PA: Temple University Press.
160. Mueller Mary Rose. 1997. “Science versus Care: Physicians, Nurses, and the Dilemma of Clinical Research.” Pp. 57–78 in The Sociology of Medical Science and Technology, edited by AM. Elston, Maiden, MA: Blackwell.
161. Mueller Mary Rose and Mamo Laura. 2000. “Changes in Medicine, Changes in Nursing: Career Contingencies and the Movement of Nurses into Clinical Trial Coordination.” Sociological Perspectives 43:S43–57.
162. National Institutes of Health (NIH). 1976. NIH Factbook: Guide to National Institutes of Health Programs and Activities. Bethesda, MD: Marquis Academic Media.
163. National Institutes of Health (NIH). 2000a. “NIH Obligations and Amounts Obligated for Grants and Direct Operations.” Retrieved July 10, 2000 (http://www.nih.gov/about/almanac/index.html).
164. National Institutes of Health (NIH). 2000b. “NIH Overview.” Retrieved July 10, 2000 (http://www.nih.gov/about/NIHoverview.html#goal).
165. National Research Council. 2000. Networking Health: Prescriptions for the Internet. Washington, DC: National Academy.
166. Navarro Vicente. 1986. Crisis, Health, and Medicine: A Social Critique. New York: Tavistock.
167. Navarro Vicente. 1999. “Health and Equity in the World in the Era of Globalization.” International Journal of Health Services Research 29:215–26.
168. Novas Carlos and Rose Nikolas. 2000. “Genetic Risk and the Birth of the Somatic Individual.” Economy and Society 29:485–513.
169. Olesen Virginia L. 2000. “Emotions and Gender in U.S. Health Care Contexts: Implications for Change and Stasis in the Division of Labour.” Pp. 315–32 in Theorizing Medical Sociology, edited by Williams S., Gabe J., and Calnan M.. London, England: Routledge.
170. Olesen Virginia L. 2002. “Resisting Fatal Unclutteredness: Conceptualising the Sociology of Health and Illness into the Millennium.” Pp. 254–66 in Gender, Health, and Healing, edited by Bendelow G., Carpenter M., Vautier C., and Williams S.. London, England: Routledge.
171. Olesen Virginia and Bone Debora. 1998. “Emotions in Rationalizing Organizations: Conceptual Notes from Professional Nursing in the USA.” Pp. 313–29 in Emotions in Social Life: Critical Themes and Contemporary Issues, edited by Bendelow G. and Williams S.. London, England: Routledge.
172. Watch Organs. 2001. “Organs Watch website.” Retrieved November 15, 2001 (http://sunsite.berkeley.edu/biotech/organswatch).
173. Oudshoorn Nelly. 2002. “Drugs for Healthy People: The Culture of Testing Hormonal Contraceptives for Women and Men.” Pp. 79–92 in Biographies of Remedies: Drugs, Medicines, and Contraceptives in Dutch and Anglo-American Healing Cultures, edited by van Heteren G. M., Gijswijt-Horstra M., and Tansey E. M.. Amsterdam, The Netherlands and Atlanta, GA: Rodopi.
174. Pantilat S. Z., Alpers A., and Wachter R. M.. 1999. “A New Doctor in the House: Ethical Issues in Hospitalist Systems.” Journal of the American Medical Association 282:171–4.
175. Parsons Talcott. 1951. The Social System. New York: Free Press.
176. Pauly Philip J. 1987. Controlling Life: Jacques Loeb and the Engineering Ideal in Biology. New York: Oxford University Press.
177. Petersen Alan. 1997. “Risk, Governance, and the New Public Health.” Pp. 189–223 in Foucault, Health, and Medicine, edited by Petersen A. and Bunton R.. New York: Routledge.
178. Pfohl Stephen J. 1985. Images of Deviance and Social Control: A Sociological History. New York: McGraw Hill.
179. Pickstone John V. 1993. “The Biographical and the Analytical: Towards a Historical Model of Science and Practice in Modern Medicine.” Pp. 23–47 in Medicine and Change: Historical and Sociological Studies of Medical Innovation, edited by Lowy I.. Montrouge, France: John Libbey Eurotext.
180. Porter Theodore M. 1995. Trust in Numbers: The Pursuit of Objectivity in Science and Public Life. Princeton, NJ: Princeton University Press.
181. Press Nancy, Fishman Jennifer R., and Koenig Barbara A.. 2000. “Collective Fear, Individualized Risk: The Social and Cultural Context of Genetic Testing for Breast Cancer.” Nursing Ethics 7:237–49.
182. Rabeharisoa Vololona and Callon Michel. 1998. “The Participation of Patients in the Process of Production of Knowledge: The Case of the French Muscular Dystrophy Association” (in French). Sciences Sociales et Sante 16:41–65.
183. Rabinow Paul. 1992. “Artificiality and Enlightenment: From Sociobiology to Biosociality.” Pp. 234–52 in Incorporations, edited by Crary J. and Kwinter S.. New York: Zone.
184. Rabinow Paul. 1996. Making PCR: A Story of Biotechnology. Chicago, IL: University of Chicago Press.
185. Radley Alan, Lupton Deborah, and Ritter Christian. 1997. “Health: An Invitation and an Introduction.” Health 1:5–21.
186. Rapp Rayna. 1999. Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America. New York: Routledge.
187. Relman Arnold S. 1980. “The Medical-Industrial Complex.” New England Journal of Medicine 303:963–70.
188. Renaud Marc. 1995. “Le Concept de Medicalisation, A t'il Toujours la Même Pertinence?” (The concept of medicalization: Is it still salient?). Pp. 167–73 in Medicalization and Social Control, edited by Bouchard L. and Cohen D.. Paris, France: Actas.
189. Reverby Susan. 1981. “Stealing the Golden Eggs: Ernest Amory Codman and the Science and Management of Medicine.” Bulletin of the History of Medicine 55:156–71.
190. Riccardi Nicholas and Monmaney Terence. 2000. “King/Drew Medical Research Suspended.” Los Angeles Times, April 27, p. 1.
191. Riessman Catherine Kohler. 1983. “Women and Medicalization: A New Perspective.” Social Policy 14:3–18.
192. Risse Guenter B. 1999. Mending Bodies, Saving Souls: A History of Hospitals. New York: Oxford University Press.
193. Robinson James C. 1999. The Corporate Practice of Medicine: Competition and Innovation in Health Care. Berkeley, CA: University of California Press.
194. Rockhill Beverly, Spiegelman Donna, Byrne Celia, Hunter David J., and Colditz Graham. 2001. “Validation of the Gail et al. Model of Breast Cancer Risk Prediction and Implications for Chemoprevention.” Journal of the National Cancer Institute 93:358–66.
195. Rogers Richard, ed. 2000. Preferred Placement: Knowledge Politics on the Web. Maastrict, The Netherlands: Jan van Eyk Editions.
196. Rose Nikolas. 1994. “Medicine, History, and the Present.” Pp. 48–72 in Reassessing Foucault: Power, Medicine, and the Body, edited by Jones C. and Porter R.. London, England: Routledge.
197. Rose Nikolas. 1996. “The Death of the Social? Re-figuring the Territory of Government.” Economy and Society 25:327–56.
198. Rothman Barbara Katz. 1998. Genetic Maps and Human Imaginations: The Limits of Science in Understanding Who We Are. New York: Norton.
199. Russell Sabin and Abate Tom. 2001. “Shutdown Puts Spotlight on Human Research: Experts Say Johns Hopkins Case Reflects Problems Across the U.S.” San Francisco Chronicle, July 21, p. A1.
200. Ruzek Sheryl. 1978. The Women's Health Movement: Feminist Alternatives to Medical Control. New York: Praeger.
201. Ruzek Sheryl. 1980. “Medical Response to Women's Health Activities: Conflict, Cooperation, Accommodation, and Cooptation.” Pp. 325–54 in Research in the Sociology of Health Care, edited by Roth J. A.. Stamford, CT: JAI Press.
202. Ruzek Sheryl B. and Hill Jane. 1986. “Promoting Women's Health: Redefining the Knowledge Base and Strategies for Change.” Health Promotion 1:301–9.
203. Ruzek Sheryl B., Olesen Virginia L., and Clarke Adele E., eds. 1997. Women's Health: Complexities and Differences. Columbus, OH: Ohio State University Press.
204. Salmon J. Warren. 1990. “Profit and Health Care: Trends in Corporatization and Proprietarization.” Pp. 55–77 in The Corporate Transformation of Health Care: Issues and Directions, edited by Salmon J.W.. Amityville, NY: Baywood.
205. Scheper-Hughes Nancy. 2000. “The Global Traffic in Human Organs.” Current Anthropology 41:191–224.
206. Schiller Dan. 1999. Digital Capitalism: Networking the Global Market System. Cambridge, MA: MIT Press.
207. Schneider Joseph W. and Conrad Peter. 1980. “The Medical Control of Deviance: Contests and Consequences.” Pp. 1–53 in Research in the Sociology of Health Care, edited by Roth J. A.. Stamford, CT: JAI Press.
208. Shim Janet K. 2000. “Bio-Power and Racial, Class, and Gender Formation in Biomedical Knowledge Production.” Pp. 173–95 in Research in the Sociology of Health Care, vol. 17, edited by Kronenfeld J. J.. Stamford, CT: JAI Press.
209. Shim Janet K. 2002a. “Race, Class, and Gender across the Science-Lay Divide: Expertise, Experience, and ‘Difference’ in Cardiovascular Disease.” Ph.D. dissertation, Department of Social and Behavioral Sciences, University of California, San Francisco, CA.
210. Shim Janet K. 2002b. “Understanding the Routinised Inclusion of Race, Socioeconomic Status, and Sex in Epidemiology: The Utility of Concepts from Technoscience Studies.” Sociology of Health and Illness 24:138–50.
211. Shostak Sara. 2001. “Locating Molecular Bio-markers, Relocating Risk.” Paper presented at the annual meeting of the Society for Social Studies of Science, November 1–4, Cambridge, MA.
212. Smith Merritt Roe and Marx Leo, eds. 1994. Does Technology Drive History? The Dilemma of Technological Determinism. Cambridge, MA: MIT Press.
213. Smith Vicki. 1997. “New Forms of Work Organizations.” Annual Review of Sociology 23: 315–39.
214. Spivak Gayatri Chakravorty. 1988. In Other Worlds: Essays in Cultural Politics. New York: Routledge.
215. Star Susan Leigh, ed. 1995. The Cultures of Computing. Oxford, England: Basil Blackwell.
216. Starr Paul. 1982. The Social Transformation of American Medicine. New York: Basic.
217. Stevens Rosemary. 1998. American Medicine and the Public Interest: A History of Specialization. Berkeley, CA: University of California Press.
218. Strauss Anselm. 1993. Continual Permutations of Action. New York: Aldine de Gruyter.
219. Strauss Anselm L. and Corbin Juliet. 1988. Shaping a New Health Care System: The Explosion of Chronic Illness as a Catalyst for Change. San Francisco, CA: Jossey-Bass.
220. Strauss Anselm, Corbin Juliet, Fagerhaugh Shizuko, Glaser Barney G., Maines David, Suczek Barbara, and Wiener Carolyn L., eds. 1984. Chronic Illness and the Quality of Life. 2d ed. St. Louis, MO and Toronto, Canada: C. V. Mosby.
221. Strauss Anselm L. and Glaser Barney. 1975. Chronic Illness and the Quality of Life. St. Louis, MO: C. V. Mosby.
222. Strauss Anselm, Schatzman Leonard, Bucher Rue, Erlich Danuta, and Sabshin Melvin. 1964. Psychiatric Ideologies and Institutions. Glencoe, IL: Free Press.
223. Swan John P. 1990. “Universities, Industry, and the Rise of Biomedical Collaboration in America.” Pp. 73–90 in Pill Peddlers: Essays on the History of the Pharmaceutical Industry, edited by Liebman J., Higby G.J., and Stroud E.C.. Madison, WI: American Institute of the History of Pharmacy.
224. Tesh Sylvia Noble. 1990. Hidden Arguments: Political Ideology and Disease Prevention Policy. New Brunswick, NJ: Rutgers.
225. Timmermans Stefan. 1999. Sudden Death and the Myth of CPR. Philadelphia, PA: Temple University Press.
226. Timmermans Stefan. 2000. “Technology and Medical Practice.” Pp. 309–21 in Handbook of Medical Sociology, edited by Bird C. E., Conrad P., and Fremont A.M.. Upper Saddle River, NJ: Prentice Hall.
227. Timmermans Stefan and Berg Marc. 1997. “Standardization in Action: Achieving Local Universality through Medical Protocols.” Social Studies of Science 27:273–305.
228. Traynor Michael. 2000. “Purity, Conversion, and the Evidence Based Movements.” Health 4:139–58.
229. Turner Bryan S. 1984. The Body and Society. Oxford, England: Basil Blackwell.
230. Turner Bryan S. 1992. Regulating Bodies: Essays in Medical Sociology. London, England: Routledge.
231. Turner Bryan S. 1997. “From Governmentality to Risk: Some Reflections on Foucault's Contribution to Medical Sociology.” Pp. ix–xxii in Foucault, Health, and Medicine, edited by Petersen A. and Bunton R.. London, England: Routledge.
232. Vaughan Diane. 1996. The Challenger Launch Decision. Chicago, IL: University of Chicago Press.
233. Vaughan Diane. 1999. “The Role of the Organization in the Production of Techno-Scientific Knowledge.” Social Studies of Science 29:913–43.
234. Waitzkin Howard. 1989. “Social Structures of Medical Oppression: A Marxist View.” Pp. 166–78 in Perspectives in Medical Sociology, edited by Brown P.. Belmont, CA: Wadsworth.
235. Waitzkin Howard. 1991. The Politics of Medical Encounters: How Patients and Doctors Deal with Social Problems. New Haven, CT: Yale University Press.
236. Waitzkin Howard. 2001. At the Front Lines of Medicine. Blue Ridge Summit, PA: Rowman and Littlefield.
237. Waitzkin Howard and Fishman Jennifer. 1997. “Inside the System: The Patient-Physician Relationship in the Era of Managed Care.” Pp. 136–62 in Competitive Managed Care: The Emerging Health Care System, edited by Wilkerson J. D., Devers K.J., and Given R.S.. San Francisco, CA: Jossey-Bass.
238. Wayne Leslie and Petersen Melody. 2001. “A Muscular Lobby Rolls Up Its Sleeves.” New York Times, November 4, pp. BU1,13.
239. Weinstein Deena and Weinstein Michael A.. 1999. “McDonaldization Enframed.” Pp. 57–69 in Resisting McDonaldization, edited by Smart B.. London, England: Sage.
240. Weiss R.B., Rifkin R.M., Stewart F.M., Theriault R.L., Williams L.A., Herman A. A., and Beveridge R. A.. 2000. “High-Dose Chemotherapy for High Risk Primary Breast Cancer: An On-Site Review of the Bezwoda Study.” Lancet 355:999–1003.
241. Wells Stacey. 2001. “Industry Outlook: Biotechnology—Why Bioinformatics Is a Hot Career.” San Francisco Chronicle, March 4, p. J-1.
242. Whiteis David G. and Warren Salmon J.. 1990. “The Proprietarization of Health Care and the Underdevelopment of the Public Sector.” Pp. 117–31 in The Corporate Transformation of Health Care: Issues and Directions, edited by Salmon J. W.. Amityville, NY: Baywood.
243. Wiener Carolyn. 2000. The Elusive Quest: Accountability in Hospitals. Hawthorne, NY: Aldine de Gruyter.
244. Williams Simon J. 1998. “Health as Moral Performance: Ritual, Transgression, and Taboo.” Health 2:435–57.
245. Williams Simon J. 1999. “Transgression for What? A Response to Robert Crawford.” Health 3:367–78.
246. Williams Simon J. and Calnan Michael. 1994. “Perspectives on Prevention: The Views of General Practitioners.” Sociology of Health and Illness 16:372–93.
247. Woloshin Steve, Schwartz Lisa M., Tremmel Jennifer, and Gilbert Welch H.. 2001. “Direct-to-Consumer Advertisements for Prescription Drugs: What Are Americans Being Sold?” Lancet 358:1141–46.
248. Worcester Nancy and Whatley Marianne. 1988. “The Response of the Health Care System to the Women's Health Movement: The Selling of Women's Health Centers.” Pp. 117–51 in Feminism within the Science and Health Care Profession: Overcoming Resistance, edited by Rosser S. V.. New York: Pergamon.
249. Writing Group for the Women's Health Initiative Investigators. 2002. “Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women's Health Intuitive Randomized Controlled Trial.” Journal of the American Medical Association 288(3):321–33.
250. Yates Joanne and Van Maanen John, eds. 2001. Information Technology and Organizational Transformation: History, Rhetoric, and Practice. Thousand Oaks, CA: Sage.
251. Zola Irving Kenneth. 1972. “Medicine as an Institution of Social Control.” Sociological Review 20:487–504.
252. Zola Irving Kenneth. 1991. “Bringing Our Bodies and Ourselves Back In: Reflections on a Past, Present, and Future ‘Medical Sociology.”’ Journal of Health and Social Behavior 32:1–16.
253. Zones Jane S. 2000. “Profits from Pain: The Political Economy of Breast Cancer.” Pp. 119–51 in Breast Cancer: Society Constructs an Epidemic, edited by Ferguson S.J. and Kasper A.S.. New York: St. Martin's.